Product image of Irbesartán Sun (Irbesartan) supplied by GNH India

Irbesartán Sun

Active Ingredient:
Irbesartan
Origin:
EU

Irbesartán Sun (Irbesartan)

Irbesartan, the active ingredient in Irbesartán Sun, is an Angiotensin II receptor blocker (ARB) presented as a tablet for oral use. It reduces blood pressure and slows progression of kidney damage in adults with hypertension, including those who have type 2 diabetes‑related nephropathy.

GNH India supplies Irbesartán Sun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable access to quality‑assured medicines across regulated markets.

Manufacturer / TM Owner

Sun Pharmaceutical Industries Europe B.V.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Irbesartan is used to manage conditions related to the renin‑angiotensin system, primarily hypertension and diabetic kidney disease.

  • Hypertension: lowers elevated blood pressure, helping to prevent cardiovascular complications.
  • Diabetic nephropathy: slows the decline of renal function in patients with type 2 diabetes‑related kidney disease.
  • Proteinuria: reduces urinary protein excretion, contributing to renal protection.

How It Works

  • Irbesartan selectively blocks the angiotensin II type 1 (AT1) receptor, preventing angiotensin II from binding and activating the receptor. This inhibition leads to vasodilation, reduced aldosterone secretion, decreased sodium and water retention, and ultimately lower systemic vascular resistance and blood pressure.

Side Effects

Common Side Effects

  • Dizziness: sensation of light‑headedness, especially after standing.
  • Headache: mild to moderate head pain.
  • Fatigue: feeling unusually tired or weak.
  • Nasal congestion: blocked or runny nose.
  • Back pain: discomfort in the lower back region.
  • Increased serum creatinine: modest rise in kidney function marker.

Serious or Rare Side Effects

  • Angioedema: swelling of face, lips, tongue, or throat that may impair breathing.
  • Hyperkalemia: elevated potassium levels that can affect heart rhythm.
  • Acute renal failure: sudden loss of kidney function.
  • Hepatic injury: signs of liver damage such as jaundice or elevated enzymes.

Precautions & Warnings

Before starting Irbesartán Sun, patients and clinicians should consider several safety measures.

  • Blood pressure monitoring: check regularly to ensure therapeutic control.
  • Renal function assessment: evaluate serum creatinine and eGFR at baseline and periodically.
  • Serum potassium: monitor for hyperkalemia, especially if using potassium‑sparing agents.
  • Pregnancy: avoid use in pregnancy due to fetal risk (Category D).
  • Hepatic impairment: use with caution in patients with liver disease.
  • Store at ambient temperature: keep in the original pack, protect from moisture and direct sunlight.

Avoid Interactions

Irbesartán Sun may interact with other medicines; awareness of the interaction level guides management.

Major Interactions (Avoid)

  • Aliskiren in diabetic patients: combined use can increase renal risk.
  • Dual blockade with ACE inhibitors or other ARBs: may cause excessive hypotension and renal dysfunction.
  • Potassium‑sparing diuretics (e.g., spironolactone): heightens risk of hyperkalemia.
  • NSAIDs (high dose): can impair renal function and blunt antihypertensive effect.

Moderate Interactions (Monitor Closely)

  • Thiazide diuretics: may enhance antihypertensive effect, requiring dose adjustment.
  • Lithium: increased lithium levels, necessitating serum monitoring.

Frequently Asked Questions

Irbesartán Sun contains irbesartan, an ARB prescribed to lower high blood pressure and to protect kidney function in adults with hypertension, including those who have diabetic nephropathy. It is part of standard therapy for managing the renin‑angiotensin system in these patient groups.

Irbesartan blocks the angiotensin II type 1 (AT1) receptor, preventing angiotensin II from causing vasoconstriction and aldosterone release. This results in relaxed blood vessels, reduced sodium and water retention, and ultimately lower blood pressure and decreased stress on the kidneys.

The specific dose of Irbesartán Sun is determined by the prescribing clinician based on the individual’s blood pressure, kidney function, and overall health status. Patients should follow the exact regimen written on their prescription and not adjust the dose on their own.

Irbesartán Sun is classified as Pregnancy Category D, indicating evidence of fetal risk. It should be avoided in pregnancy. Limited data are available for breastfeeding, and the drug may pass into breast milk, so use is generally not recommended without medical advice.

To order Irbesartán Sun, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Irbesartan belongs to the ARB class, offering blood‑pressure control similar to ACE inhibitors but with a lower incidence of cough. Compared with other ARBs, its efficacy and safety profile are comparable, and it is often chosen for patients who cannot tolerate ACE‑inhibitor‑related side effects.

Irbesartán Sun should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the tablets away from moisture, direct sunlight, and excessive heat to maintain potency throughout its shelf life.

Irbesartán Sun is taken orally, usually once daily with or without food, as directed by a healthcare professional. Swallow the tablet whole with a glass of water; do not crush or split unless specifically instructed by the prescriber.

The most serious risks include angioedema, which can cause swelling of the face or throat, severe hyperkalemia that may affect heart rhythm, and acute kidney injury, especially when combined with other nephrotoxic agents or in patients with pre‑existing renal impairment.

Irbesartán Sun should not be used by individuals with known hypersensitivity to irbesartan or any component of the formulation, pregnant women, or patients with severe hepatic impairment. Caution is also advised for those with bilateral renal artery stenosis or uncontrolled hyperkalemia.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Irbesartan

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT